Products

DeepHealth (formerly Kheiron Medical Technologies)
DeepHealth (formerly Kheiron Medical Technologies)
Clinical Decision Support & Reference
Mia is an AI-powered solution, now part of DeepHealth's SmartMammo™ Breast Suite, designed to enhance breast cancer detection and diagnostic workflow efficiency for radiologists.

See all 1 product →

About DeepHealth (formerly Kheiron Medical Technologies)

DeepHealth, formerly Kheiron Medical Technologies, is a healthcare AI company focused on empowering breakthroughs in care through imaging. As a wholly-owned subsidiary of RadNet, Inc., DeepHealth provides AI-powered health informatics solutions designed to enhance operational efficiency and improve clinical outcomes across various areas, including breast, chest, musculoskeletal, neuro, prostate, and thyroid health. Their portfolio includes an AI-powered, cloud-native operating system, DeepHealth OS, which unifies data across clinical and operational workflows and personalizes AI-powered workspaces for radiologists. The company’s solutions are utilized by thousands of imaging centers and radiology departments globally to enable earlier, more reliable, and more efficient disease detection, particularly in large-scale cancer screening programs.

For physicians, DeepHealth offers a comprehensive suite of AI-powered tools aimed at streamlining diagnostic workflows and improving diagnostic accuracy. Their Breast Suite, for example, provides enhanced workflow and diagnostic accuracy in breast cancer detection, with studies demonstrating increased cancer detection rates. The company also offers solutions like the Diagnostic Suite™ for a unified diagnostic workspace with PACS functionality and advanced image management, and the Operations Suite™ for smart operations with RIS functionality and real-time workflow management. DeepHealth’s commitment to clinical rigor is evident in their extensive clinical studies, which aim to prove the effectiveness and safety of their AI solutions across diverse patient populations and equipment. DeepHealth’s offerings are designed to address challenges such as workforce constraints, rising imaging volumes, and the need for consistent, high-quality diagnostic pathways, ultimately enabling healthcare systems to move from reactive treatment to proactive intervention.

What Physicians Need to Know

Specialization
DeepHealth specializes in AI-powered health informatics for diagnostic imaging, focusing on early and efficient disease detection, assessment, and monitoring across various modalities including mammography, MRI, CT, X-ray, and ultrasound.
Key Differentiators
DeepHealth offers a comprehensive portfolio of native clinical AI solutions spanning multiple imaging modalities and an end-to-end suite of modular AI solutions validated by clinical evidence. Their technology has demonstrated increased cancer detection rates, particularly in breast cancer screening, and improved diagnostic accuracy and efficiency for radiologists.
Technology Stack
At the core of DeepHealth's portfolio is DeepHealth OS, a cloud-native operating system that unifies data across clinical and operational workflows. They leverage Google Cloud, including the Healthcare API, Gemini Enterprise Agent Platform for radiology workflows, BigQuery for data cohort creation, Looker for analytics, and MedGemma for report summarization and medical language processing.
Core Product Suites
DeepHealth offers specialized suites including Breast Suite (AI-powered detection, risk assessment, breast density analysis), Prostate Suite (enhanced prostate cancer detection), Chest Suite (nodule detection and management), Neuro Suite (neurodegenerative changes assessment), and Thyroid Suite (AI-powered ultrasound imaging).
Remote Scanning and Management
DeepHealth provides TechLiveu2122, a multimodality, vendor-agnostic remote scanning and radiology management solution with 510K clearance across MR, ultrasound, CT, and PET/CT.
AI Orchestration
Their AI Studio Suite provides a unified platform to accelerate enterprise-wide AI adoption, integrating over 140 AI algorithms from more than 75 ecosystem partners and orchestrating them within the clinical workflow.
Physician Tip

For physicians, DeepHealth's AI tools aim to enhance diagnostic accuracy and consistency, enabling earlier disease detection and more proactive intervention. The Breast Suite, for example, has shown a significant increase in breast cancer detection rates, even in dense breasts and diverse patient populations, and can elevate the performance of generalist radiologists to the level of specialists. The AI-powered solutions also streamline workflows, automate tedious tasks like nodule detection and reporting in thyroid imaging, and provide risk assessments, ultimately leading to improved operational efficiency and patient outcomes. The TechLiveu2122 platform can also help overcome staffing challenges and expand access to advanced imaging procedures through remote scanning and management.

DeepHealth's solutions are designed to be cloud-native or hybrid platforms, simplifying deployment and operations. Their DeepHealth OS unifies data across clinical and operational workflows, and they actively work with leading OEMs, cloud, AI, and platform partners to integrate fragmented tools into a connected, end-to-end imaging experience. They also integrate with existing thyroid imaging workflows and technology. DeepHealth's AI Studio Suite orchestrates over 140 AI algorithms from more than 75 ecosystem partners within the clinical workflow, including the worklist, viewer, reporting modules, and workflow engine.

Products by DeepHealth (formerly Kheiron Medical Technologies)

1 product in the directory

DeepHealth (formerly Kheiron Medical Technologies)
DeepHealth (formerly Kheiron Medical Technologies)
Clinical Decision Support & Reference
Mia is an AI-powered solution, now part of DeepHealth's SmartMammo™ Breast Suite, designed to enhance breast cancer detection and diagnostic workflow efficiency for radiologists.

What the Web Says

DeepHealth, formerly Kheiron Medical Technologies, is an AI-powered health informatics company specializing in solutions for cancer detection and screening, particularly in mammography. The company's AI tools aim to improve diagnostic accuracy, workflow efficiency, and standardization of care across various imaging modalities like breast, lung, prostate, and brain health. DeepHealth was acquired by RadNet, Inc. and its products, such as Mia (Mammography Intelligent Assessment) and Smart Mammo, are designed to assist radiologists in identifying malignancies and streamlining reporting processes. While product reviews highlight the potential for earlier and more accurate cancer detection, employer reviews present a mixed picture regarding work environment and career advancement.

Overall: Mixed

Strengths

  • AI-powered solutions improve breast cancer detection rates and accuracy.
  • AI tools can reduce radiologist workload and interpretation times.
  • Products aim to enhance workflow efficiency and standardize care.
  • Cloud-native platform unifies imaging data and integrates with existing healthcare systems.
  • Emphasis on professional growth, staff well-being, and quality patient care (employer perspective).
  • Collaborative work environment (employer perspective).

Limitations

  • Lack of opportunities for quick advancement or innovation (employer perspective).
  • Compensation and benefits may not be competitive compared to industry standards (employer perspective).
  • Stressful work environment and long hours at times (employer perspective).
  • Management issues and lack of flexibility (employer perspective).
  • High employee turnover in some roles (employer perspective).
  • Limited number of recognized holidays compared to other large corporations (employer perspective).

Based on reviews from: Deephealth Average Salary, Pay Ranges & Benefits, DeepHealth Pricing & Reviews 2026 | Techjockey.com, RadNet Manager (DeepHealth) Review: Kind of run like a mid-tier private equity firm, Evidence - DeepHealth, Kheiron Medical Technology can Detect Cancer with AI Test - AI Magazine, Kheiron Medical Technologies - AuntMinnie, KHEIRON Careers and Employment | Indeed.com, Kheiron Launches AI Tools to Improve Breast Cancer Screening - Unite.AI, Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening - PMC, DeepHealth - 2026 Company Profile, Team, Funding & Competitors - Tracxn, ECR - DeepHealth, Kheiron Medical Technologies 2026 Company Profile: Valuation, Investors, Acquisition, DeepHealth Showcases AI Radiology Solutions at ECR 2025 : r/ArtificialNtelligence - Reddit, Careers - DeepHealth, Am I getting scammed by this company, which provides training in clinical research? : r/clinicalresearch - Reddit, DeepHealth - Radiology AI-Powered Health Informatics | RadNet, DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite | RadNet Inc, DeepHealth gets FDA nod for AI tool that reads ultrasounds, creates reports, Three Papers in the Eye of the 'AI Breast Cancer Detection' Storm : r/compsci - Reddit, Deephealth Expands Its AI-Powered Cancer Diagnostic and Screening Portfolio with the Acquisition of Kheiron, Working at Chiron: Employee Reviews | Indeed.com, Best Electronic Medical Records Software 2026 - Capterra, DeepHealth Unveils Industry's Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026 - RadNet, DeepHealth Strengthens AI Breast Cancer Screening Position with Kheiron Acquisition, DeHealth Reviews 2026: Details, Pricing, & Features - G2, Chiron Health Reviews 2026: Details, Pricing, & Features - G2, Working at Kedrion Biopharma: Company Overview and Reviews - SimplyHired, GE Healthcare Products | Read 19 Reviews on G2, Working at Kheir Clinic (FQHC): Employee Reviews | Indeed.com, Working at Koher Medical: Employee Reviews | Indeed.com

Last updated: 2026-09-20

Videos

News, demos, and interviews about DeepHealth (formerly Kheiron Medical Technologies).

Loading videos...

Videos load interactively. If none appear, search YouTube for DeepHealth (formerly Kheiron Medical Technologies) →

View all on YouTube

Press & Coverage

SPI Medical Imaging
DeepHealth Expands its Breast AI Capabilities with Kheiron
DeepHealth has acquired UK-based AI cancer diagnostic company Kheiron Medical Technologies, integrating Kheiron's Mia suite of AI solutions for breast cancer screening into its portfolio. This acquisition aims to enhance DeepHealth's offerings for large-scale diagnostic and screening programs and expand its presence in the European market.
2024-11
Medium (Amine Korchi MD)
Shocking Acquisition: Kheiron Medical, a Pioneer in AI Breast Cancer Detection, Acquired by RadNet and DeepHealth for Just $1 Million USD
Kheiron Medical, a pioneer in AI for breast cancer detection with CE-marked software deployed in Europe and the UK, was acquired by RadNet and DeepHealth for $1 million USD. The author suggests this surprisingly low price highlights the challenges in healthcare AI beyond technology, emphasizing the need for strong commercial organization and sales strategy.
2024-11
DeepHealth
Deephealth Expands Its AI-Powered Cancer Diagnostic and Screening Portfolio with the Acquisition of Kheiron
DeepHealth has acquired Kheiron Medical Technologies Limited, a UK-based AI cancer diagnostic company. Kheiron's Miau00ae suite of AI solutions for breast cancer screening will complement DeepHealth's existing portfolio, aiming to improve early breast cancer detection globally.
2024-10
Signify Research
AI in Medical Imaging News Round Up – October 2024
DeepHealth announced the acquisition of UK-based Kheiron Medical Technologies Ltd., whose Mia product detects breast cancer from mammograms. This acquisition will expand DeepHealth's AI portfolio to include breast, lung, and prostate solutions, supporting further expansion into Europe.
2024-11
AI Magazine
Kheiron Medical Technology can Detect Cancer with AI Test
Mia, an AI tool developed by Kheiron Medical Technologies, successfully identified subtle signs of breast cancer missed by human doctors. This AI solution, partnered with Microsoft, NHS Grampian, and the University of Aberdeen, could increase breast cancer detection by 12% across the NHS.
2024-03
Imperial College London
New AI tool detects up to 13% more breast cancers than humans alone | Imperial News
A new AI tool called Mia, developed by Kheiron Medical Technologies and Imperial College London, can detect up to 13% more breast cancers than human readers in screenings. Published in Nature Medicine, this prospective evidence suggests Mia could significantly increase early detection in European healthcare settings.
2023-11
MedTech Innovator
Kheiron Medical Technologies and Microsoft Join Forces To Support Breast Cancer Detection
Kheiron Medical Technologies announced a collaboration with Microsoft to use Microsoft's Azure Cloud for its AI solution, Miau00ae, to aid in earlier breast cancer detection. Miau00ae is currently deployed at 4 sites in Europe and 15 NHS sites in the UK, aiming to screen over half a million women annually.
2022-11
PMC (Nature Medicine)
Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms - PMC
A multi-vendor evaluation of Kheiron Medical Technologies' Miau2122 version 2.0 AI system, published in Nature Medicine, analyzed 275,900 mammograms. The study found that using AI as an independent reader showed non-inferior recall rates, cancer detection rates, sensitivity, specificity, and positive predictive value compared to human double reading.
2023-05

Frequently Asked Questions

DeepHealth offers a comprehensive portfolio of AI-powered solutions across various imaging modalities, including Breast, Prostate, Chest, Neuro, Thyroid, and Musculoskeletal Suites. These solutions aim to enhance diagnostic accuracy, improve workflow efficiency, and standardize care. For example, their Breast Suite includes AI for cancer detection, density assessment, and risk assessment, while the Neuro Suite assists in assessing and monitoring neurodegenerative changes.
DeepHealth is committed to complying with applicable privacy and data protection laws like GDPR and UK GDPR. They implement robust technical and organizational safeguards, including ISO 27001 certification, for information security. While their website privacy policy focuses on website data, they state that protected health information in clinical products is governed by contracts and Business Associate Agreements.
DeepHealth's AI tools have demonstrated significant efficacy in clinical studies. For instance, their Breast Suite applications showed a 21% increase in breast cancer detection rates in a large real-world analysis in the U.S., with consistent benefits across diverse patient populations. Their Prostate AI solution detected 27% more lesions and reduced inter-radiologist segmentation variability by 65%. Additionally, their AI tool Mia (from the acquired Kheiron Medical Technologies) has been shown to detect up to 13% more breast cancers than humans alone in European settings.
DeepHealth emphasizes seamless integration into existing workflows and IT infrastructure. Their cloud-native operating system, DeepHealth OS, unifies data across clinical and operational workflows and personalizes AI-powered workspaces. They also offer solutions like TechLiveu2122 for remote scanning and radiology management, designed for quick deployment and RIS integration to address staffing challenges and expand services.
DeepHealth has strategic partnerships to expand access and capabilities. They have an expanded collaboration with GE HealthCare to advance AI-powered mammography tools globally and integrate AI into ultrasound imaging. They also partner with companies like Incepto to distribute their AI solutions across Europe. These partnerships aim to bring advanced AI to more providers, enhance diagnostic confidence, and improve operational efficiency.
DeepHealth is a wholly-owned subsidiary of RadNet, Inc., a leading national provider of diagnostic imaging services in the United States. This acquisition by RadNet in 2020, and subsequent acquisitions of other AI firms like Kheiron Medical Technologies, Quantib, and Aidence, indicates a strong financial backing and a strategic focus on expanding DeepHealth's AI portfolio. DeepHealth's continued growth in revenue and customer momentum contribute to RadNet's financial results.
While specific details on bias audits for all products are not extensively detailed, DeepHealth states that for recruitment decisions involving AI, a final hiring decision is never made solely on automated processing and requires substantive human review and intervention. In their breast cancer screening studies, they have shown consistent benefits across diverse patient populations, including women with dense breasts and Black, non-Hispanic women, suggesting an equitable impact.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.